Pharmacokinetics of Cenobamate: Results From Single and Multiple Oral Ascending‐Dose Studies in Healthy Subjects

Cenobamate (YKP3089) is an antiepileptic drug recently approved by the Food and Drug Administration for the treatment of focal (partial‐onset) seizures in adults. The objectives of a first‐in‐human single‐ascending‐dose study and 3 multiple‐ascending‐dose studies were to characterize the pharmacokin...

Full description

Saved in:
Bibliographic Details
Published inClinical pharmacology in drug development Vol. 9; no. 4; pp. 428 - 443
Main Authors Vernillet, Laurent, Greene, Stephen A., Kamin, Marc
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.05.2020
Subjects
Online AccessGet full text

Cover

Loading…